According to the Mayo Clinic, Post-traumatic Stress Disorder (PTSD) "is a mental health condition that's triggered by a terrifying event—either experiencing it or witnessing it." The famous clinic listed PTSD symptoms that include "flashbacks, nightmares, severe anxiety, and uncontrollable thoughts about the trigger event."
During the past year, almost four percent of adults in the United States experienced PTSD. According to official reports, this condition is suffered more by women than men, with about five percent of women diagnosed with PTSD while just under two percent of men are diagnosed. Over their entire lifetimes, about seven percent of adults in the U.S. experience PTSD.
A 2021 peer-reviewed research study entitled "Use of Cannabinoids for the Treatment of Patients with Post-traumatic Stress Disorder" that was published in the Journal of Basic and Clinical Physiology and Pharmacology investigated the potential therapeutic support provided by the cannabinoids produced by cannabis and hemp for PTSD.
The study reported that current PTSD treatment options "include various psychotherapies, but not all patients respond to them." Thus, medical doctors, psychiatrists, and other wellness professionals are continually seeking "different pharmacological approaches...as potential adjuvants, including using cannabinoids to target the endocannabinoid system to reduce the symptoms" [of PTSD, including] "associated fear memories," wrote the researchers.
The study found that cannabinoids such as CBD and THC "were shown to improve overall PTSD symptoms, including sleep quality and quantity, hyper-arousal, and treatment-resistant nightmares."
The research concluded that the prior studies it evaluated "reveal promising evidence in favor of cannabinoids as a treatment option for individuals with PTSD." Its authors described the cannabinoids CBD and THC as "effective treatments for PTSD symptoms overall, as well as enhancing consolidation of extinction training used to eliminate conditioned fear."
Read more and Learn More at: Higher Learning LV
